Today’s Top Three in Pharma Cinco de Mayo

Abbott and J&J to duke it out in court over a patent dispute on new rheumatoid arthritis drug.

Amylin eliminating 200 sales positions – Drugmaker Amylin Pharmaceuticals Inc. said Monday it will eliminate about 200 jobs, or more than a third of its sales force, as it combines its primary care and specialty drug sales units.Amylin partners with Eli Lilly & Co. to sell the diabetes drug Byetta, and is also developing a once-per-week version through that alliance. Amylin said the reorganization of its sales force will strengthen the partnership.

Gelnique works for OAB – Applying a gel containing the anti-spasmodic agent oxybutynin to the skin is safe and effective for women with overactive bladder, according to a study reported here at the annual meeting of the American Urological Association.

——

Subscribe to the Impactiviti blog via e-mail

Subscribe to the Impactiviti blog via RSS

Connect with Steve Woodruff